OMZ powder for injection
Ferron Par Pharmaceuticals
Ingredients in every vial
| Omeprazole | 40 mg |
Each package contains
Other details
| Flavour | None |
W.H.O. classification
| ATC Level 1 | A - Alimentary tract and metabolism |
| ATC Level 2 | A02 - Drugs for Acid Related Disorders |
| ATC Level 3 | A02A - Antacids |
Warnings
Pregnancy
Lactation
Alcohol
Machinery
Available in
 |
Indonesia |
Dosage information
18 YEARS OLD AND ABOVE
Omeprazole intravenous should only be used where oral medication is inappropriate, e.g. in severely ill patients. Dose 40 mg once daily.
For the treatment of Zollinger-Ellison syndrome, dosage must be adjusted according to the individual response.
Dilute OMZ® injection with 10 ml WFI, do not use another solvent. Inject over a period of not less than 2.5 minutes. Inject at a rate no greater than 4 ml/min.
UP TO 18 YEARS
There is no experience with omeprazole injection in children.
Dilute OMZ® injection with 10 ml WFI, do not use another solvent. Inject over a period of not less than 2.5 minutes. Inject at a rate no greater than 4 ml/min.
PATIENTS WITH SEVERE RENAL IMPAIRMENT
No dosage adjustment of OMZ® injection is necessary.
PATIENTS WITH SEVERE HEPATIC IMPAIRMENT
No dosage adjustment of OMZ® injection is necessary.
ELDERLY PATIENTS
No dosage adjustment of OMZ® injection is necessary.
Indication
Alternative therapy for the following conditions which cannot be treated effectively with oral medication: duodenal ulcer, gastric ulcer, reflux esophagitis and Zollinger-Ellison syndrome.